Immatics NV (IMTX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1251031,
    "name": "Immatics NV",
    "stock_name": "Immatics NV",
    "full_name": "Immatics NV",
    "name_url": "stocks-analysis/immatics-nv",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "11.87",
    "chg": 1.98,
    "chgp": "20.02%",
    "dir": 1,
    "prev_price": "9.89",
    "mcapval": "706.21",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "NL0015285941",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.03 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/immatics-nv-1251031-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Immatics NV Stock Hits Day Low of USD 8.86 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immatics-nv-stock-hits-day-low-of-usd-886-amid-price-pressure-3676170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ImmaticsNV_priceRelatedfactors_3676170.png",
        "date": "2025-11-06 16:24:31",
        "description": "Immatics NV, a small-cap biotechnology firm, faced a significant stock decline today, reaching an intraday low. Over the past week and month, the stock has shown notable decreases. Despite a positive year-to-date return, the company struggles with negative financial metrics and has underperformed compared to the broader market."
      },
      {
        "title": "Immatics NV Hits Day High with 10.2% Surge Amid Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immatics-nv-hits-day-high-with-102-surge-amid-strong-intraday-performance-3608178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmaticsNV_priceRelatedfactors_3608178.png",
        "date": "2025-10-09 21:05:23",
        "description": "Immatics NV, a small-cap biotechnology firm, experienced a notable stock surge today, contrasting with a slight decline in the S&P 500. Despite recent gains over the past week and month, the company faces longer-term challenges, including negative EBITDA and a market capitalization of USD 706 million."
      },
      {
        "title": "Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immatics-nvs-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3601363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmaticsNV_technicaldot_3601363.png",
        "date": "2025-10-07 20:59:29",
        "description": "Immatics NV, a small-cap biotechnology firm, has seen its stock price slightly decrease to $9.39, following a year marked by significant volatility. The company has outperformed the S&P 500 in recent weeks and months, but longer-term performance reveals challenges compared to broader market trends."
      },
      {
        "title": "Is Immatics NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-immatics-nv-technically-bullish-or-bearish-3599404",
        "imagepath": "",
        "date": "2025-10-07 12:26:14",
        "description": "As of 3 October 2025, the technical trend for Immatics NV has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe. However, the monthly KST is bearish, and the RSI shows no signal on both weekly and monthly timeframes. Overall, the Dow Theory is mildly bullish on both weekly and monthly periods.\n\nIn terms of performance, Immatics NV has outperformed the S&P 500 significantly over the past week and month, with returns of 18.71% and 50.00%, respectively, compared to the S&P 500's 1.09% and 4.15%. However, over the longer term, the stock has underperformed against the benchmark in the 1-year, 3-year, 5-year, and 10-year periods...."
      },
      {
        "title": "Is Immatics NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-immatics-nv-technically-bullish-or-bearish-3592202",
        "imagepath": "",
        "date": "2025-10-05 12:01:56",
        "description": "As of 3 October 2025, the technical trend for Immatics NV has changed from mildly bullish to bullish. The current technical stance is bullish, driven by a bullish MACD on the weekly chart, bullish Bollinger Bands on both weekly and monthly charts, and a bullish daily moving average. The KST is bullish on the weekly but bearish on the monthly, indicating some mixed signals in longer time frames. Dow Theory and OBV both show mildly bullish trends on weekly and monthly charts. \n\nIn terms of performance, Immatics NV has outperformed the S&P 500 significantly over the past week (22.08% vs. 1.09%) and month (72.48% vs. 4.15%), but has underperformed over longer periods such as the year (-9.18% vs. 17.82%) and three years (-7.11% vs. 82.57%)...."
      },
      {
        "title": "Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immatics-nvs-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-recent-gains-3552669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ImmaticsNV_technicaldot_3552669.png",
        "date": "2025-09-22 18:20:34",
        "description": "Immatics NV, a microcap in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $6.70. Despite a challenging year with a -44.90% return, recent performance shows improvement, with notable gains over the past week and month, suggesting potential for recovery amid mixed technical indicators."
      },
      {
        "title": "Is Immatics NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-immatics-nv-technically-bullish-or-bearish-3548777",
        "imagepath": "",
        "date": "2025-09-20 20:25:32",
        "description": "As of 11 August 2025, the technical trend for Immatics NV has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive shift, while the monthly MACD remains bearish, indicating some caution. The daily moving averages are bullish, and the weekly Bollinger Bands also reflect a bullish stance. However, the KST and Dow Theory show mixed signals with the KST being mildly bearish on the weekly and bearish on the monthly, and Dow Theory indicating mildly bullish on the weekly but mildly bearish on the monthly.\n\nIn terms of performance, Immatics NV has outperformed the S&P 500 over the past week and month, with returns of 11.66% and 6.44% respectively, but has significantly underperformed over the longer terms, including a -45.78% return over the past year compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but with some underlying bea..."
      }
    ],
    "total": 11,
    "sid": "1251031",
    "stock_news_url": "https://www.marketsmojo.com/news/immatics-nv-1251031"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Immatics NV Stock Hits Day Low of USD 8.86 Amid Price Pressure

2025-11-06 16:24:31

Immatics NV, a small-cap biotechnology firm, faced a significant stock decline today, reaching an intraday low. Over the past week and month, the stock has shown notable decreases. Despite a positive year-to-date return, the company struggles with negative financial metrics and has underperformed compared to the broader market.

Immatics NV Hits Day High with 10.2% Surge Amid Strong Intraday Performance

2025-10-09 21:05:23

Immatics NV, a small-cap biotechnology firm, experienced a notable stock surge today, contrasting with a slight decline in the S&P 500. Despite recent gains over the past week and month, the company faces longer-term challenges, including negative EBITDA and a market capitalization of USD 706 million.

Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Indicators

2025-10-07 20:59:29

Immatics NV, a small-cap biotechnology firm, has seen its stock price slightly decrease to $9.39, following a year marked by significant volatility. The company has outperformed the S&P 500 in recent weeks and months, but longer-term performance reveals challenges compared to broader market trends.

Is Immatics NV technically bullish or bearish?

2025-10-07 12:26:14

As of 3 October 2025, the technical trend for Immatics NV has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe. However, the monthly KST is bearish, and the RSI shows no signal on both weekly and monthly timeframes. Overall, the Dow Theory is mildly bullish on both weekly and monthly periods. In terms of performance, Immatics NV has outperformed the S&P 500 significantly over the past week and month, with returns of 18.71% and 50.00%, respectively, compared to the S&P 500's 1.09% and 4.15%. However, over the longer term, the stock has underperformed against the benchmark in the 1-year, 3-year, 5-year, and 10-year periods....

Is Immatics NV technically bullish or bearish?

2025-10-05 12:01:56

As of 3 October 2025, the technical trend for Immatics NV has changed from mildly bullish to bullish. The current technical stance is bullish, driven by a bullish MACD on the weekly chart, bullish Bollinger Bands on both weekly and monthly charts, and a bullish daily moving average. The KST is bullish on the weekly but bearish on the monthly, indicating some mixed signals in longer time frames. Dow Theory and OBV both show mildly bullish trends on weekly and monthly charts. In terms of performance, Immatics NV has outperformed the S&P 500 significantly over the past week (22.08% vs. 1.09%) and month (72.48% vs. 4.15%), but has underperformed over longer periods such as the year (-9.18% vs. 17.82%) and three years (-7.11% vs. 82.57%)....

Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-09-22 18:20:34

Immatics NV, a microcap in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $6.70. Despite a challenging year with a -44.90% return, recent performance shows improvement, with notable gains over the past week and month, suggesting potential for recovery amid mixed technical indicators.

Is Immatics NV technically bullish or bearish?

2025-09-20 20:25:32

As of 11 August 2025, the technical trend for Immatics NV has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive shift, while the monthly MACD remains bearish, indicating some caution. The daily moving averages are bullish, and the weekly Bollinger Bands also reflect a bullish stance. However, the KST and Dow Theory show mixed signals with the KST being mildly bearish on the weekly and bearish on the monthly, and Dow Theory indicating mildly bullish on the weekly but mildly bearish on the monthly. In terms of performance, Immatics NV has outperformed the S&P 500 over the past week and month, with returns of 11.66% and 6.44% respectively, but has significantly underperformed over the longer terms, including a -45.78% return over the past year compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but with some underlying bea...

View All News